Spots Global Cancer Trial Database for olanzapine
Every month we try and update this database with for olanzapine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients | NCT04503668 | Gynecologic Can... | Ondansetron Dexamethasone Neurokinin-1 Re... Olanzapine Compazine | 18 Years - 89 Years | University of Michigan Rogel Cancer Center | |
| Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer | NCT05403580 | Advanced Malign... Hematopoietic a... | Olanzapine Placebo Adminis... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel | NCT02290470 | Nausea Vomiting | Olanzapine Palonosetron, D... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study | NCT02861859 | Breast Cancer | Olanzapine Olanzapine Plac... | 18 Years - | Ottawa Hospital Research Institute | |
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer | NCT05244577 | Olanzapine CINV Testicular Canc... Cisplatin | Olanzapine Tabl... Placebo | 16 Years - | Sun Yat-sen University | |
| Olanzapine in Patients With Advanced Cancer and Weight Loss | NCT00489593 | Advanced Cancer Weight Loss | Olanzapine | - | M.D. Anderson Cancer Center | |
| Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer | NCT05403580 | Advanced Malign... Hematopoietic a... | Olanzapine Placebo Adminis... Questionnaire A... | 18 Years - | Mayo Clinic | |
| A Randomized Study of Olanzapine for the Prevention of CINV in Patients Receiving Moderately Emetogenic Chemotherapy | NCT02400866 | Cancer | Olanzapine | 19 Years - | Korean South West Oncology Group | |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors | NCT05705492 | Advanced Malign... | Biospecimen Col... Computed Tomogr... Olanzapine Placebo Adminis... Questionnaire A... | 18 Years - | OHSU Knight Cancer Institute | |
| Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer | NCT00124930 | Nausea Neoplasms | Olanzapine Haldol | 18 Years - | AHS Cancer Control Alberta | |
| Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel | NCT02290470 | Nausea Vomiting | Olanzapine Palonosetron, D... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer | NCT06338683 | Advanced Cancer Olanzapine Progression Fre... | Olanzapine 2.5 ... Standard anti-t... Nutritional adv... | 18 Years - 80 Years | Qinghai Red Cross Hospital | |
| Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer | NCT05403580 | Advanced Malign... Hematopoietic a... | Olanzapine Placebo Adminis... Questionnaire A... | 18 Years - | Mayo Clinic | |
| Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer | NCT05242874 | Chemotherapy-in... | Fosaprepitant ,... Fosaprepitant ,... | 18 Years - 70 Years | Henan Cancer Hospital | |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients | NCT04939090 | Advanced Malign... Anorexia Hematopoietic a... | Olanzapine Megestrol Aceta... Questionnaire A... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| The Optimization of Antiemetic Regimen for C-RINV in LA-HNSCCs | NCT05202275 | Nausea Vomiting Head and Neck S... Radiotherapy Si... | Olanzapine | 18 Years - 70 Years | ChineseAMS | |
| Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care | NCT03679182 | Nausea Vomiting End Stage Cance... | Olanzapine | 18 Years - 65 Years | Khon Kaen University | |
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced and Incurable Solid Tumors | NCT05705492 | Advanced Malign... | Biospecimen Col... Computed Tomogr... Olanzapine Placebo Adminis... Questionnaire A... | 18 Years - | OHSU Knight Cancer Institute | |
| Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy | NCT03960151 | Germ Cell Tumor | Rolapitant Palonosetron Olanzapine Dexamethasone | 18 Years - | Hoosier Cancer Research Network | |
| Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients | NCT04503668 | Gynecologic Can... | Ondansetron Dexamethasone Neurokinin-1 Re... Olanzapine Compazine | 18 Years - 89 Years | University of Michigan Rogel Cancer Center | |
| Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients | NCT04503668 | Gynecologic Can... | Ondansetron Dexamethasone Neurokinin-1 Re... Olanzapine Compazine | 18 Years - 89 Years | University of Michigan Rogel Cancer Center | |
| Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer | NCT03571126 | Chemotherapy-in... Lung Cancer | Olanzapine Placebos | 18 Years - 70 Years | Zunyi Medical College | |
| Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study | NCT02861859 | Breast Cancer | Olanzapine Olanzapine Plac... | 18 Years - | Ottawa Hospital Research Institute | |
| Subcutaneous Olanzapine for Hyperactive or Mixed Delirium | NCT00512291 | Advanced Cancer | Olanzapine | 18 Years - | M.D. Anderson Cancer Center | |
| Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer | NCT03571126 | Chemotherapy-in... Lung Cancer | Olanzapine Placebos | 18 Years - 70 Years | Zunyi Medical College | |
| Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer | NCT03575637 | Gastric Cancer | Olanzapine | 18 Years - | Peking University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
